gvtcx

PHE - Corporate - Sickle Cell and Thalassaemia Screening Programme

Public Health England Published 17 Aug 2021 Contracts Finder

key details

Statuscomplete
Category (CPV) 75122000
Deadline20 Jul 2021
Contract start17 Aug 2021
Contract end30 Dec 2022
SME suitableYes
OCIDocds-b5fd17-dad92333-418a-494b-ad54-24f6e10cd19f

Award

SupplierValueDateStatus
Costello Medical £80,464 16 Aug 2021 active

description

Minimum acceptable performance criteria for designing test accuracy studies of cfDNA within the UK Sickle Cell and Thalassaemia Screening Programme: a decision analytic model.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
17 Aug 2021 Award (award) · 6e05bf21-167b-41da-b0d0-ab81b19d7541-461269

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.